Filing Details

Accession Number:
0001415889-21-005762
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-07 21:08:49
Reporting Period:
2021-12-04
Accepted Time:
2021-12-07 21:08:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1697362 Burkes Michael Brophy C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stook Acquisiton 2021-12-04 8,750 $0.00 67,338 No 4 M Direct
Common Stock Disposition 2021-12-07 3,501 $91.99 63,837 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2021-12-04 8,750 $0.00 8,750 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  2. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1.
  3. On March 27, 2020, the Reporting Person was granted RSUs which vest in three tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Issuer's stock price. On December 4, 2021, the Issuer's Board of Directors determined that the milestone for the third tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSUs.